Stock MIRM MIRUM PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Mirum Pharmaceuticals, Inc.

Equities

MIRM

US6047491013

Real-time Estimate Cboe BZX
Other stock markets
 02:26:23 2024-05-03 pm EDT 		5-day change 1st Jan Change
25.89 USD +1.13% Intraday chart for Mirum Pharmaceuticals, Inc. +5.89% -12.26%
Apr. 17 Stifel Initiates Mirum Pharmaceuticals With Buy Rating, $48 Price Target MT
Apr. 02 Mirum Pharmaceuticals, Inc. receives Positive Reimbursement Recommendation for Livmarli (Maralixibat Oral Solution) by Canada?S Cadth for Patients with Cholestatic Pruritus in Alagille Syndrome CI

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Dividend / Share (DPS) - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Dividend / Share (DPS)

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. MIRM Stock
  4. Revisions Mirum Pharmaceuticals, Inc.